These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37048621)

  • 21. Dosing strategies for
    Diamond A; Karhadkar S; Chavin K; Constantinescu S; Lau KN; Perez-Leal O; Mohrien K; Sifontis N; Di Carlo A
    World J Transplant; 2023 Dec; 13(6):368-378. PubMed ID: 38174147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations.
    Henin E; Govoni M; Cella M; Laveille C; Piotti G
    Adv Ther; 2021 Oct; 38(10):5317-5332. PubMed ID: 34515977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response.
    Anft M; Zgoura P; Skrzypczyk S; Dürr M; Viebahn R; Westhoff TH; Stervbo U; Babel N
    Front Transplant; 2024; 3():1405070. PubMed ID: 39386200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
    Faravardeh A; Akkina S; Villicana R; Guerra G; Moten MA; Meier-Kriesche U; Stevens DR; Patel SJ; Bunnapradist S
    Ann Transplant; 2021 Apr; 26():e929535. PubMed ID: 33859155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians.
    Wiseman A; Alhamad T; Alloway RR; Concepcion BP; Cooper M; Formica R; Klein CL; Kumar V; Leca N; Shihab F; Taber DJ; Mulnick S; Bushnell DM; Hadi M; Bunnapradist S
    Ann Transplant; 2024 Mar; 29():e943498. PubMed ID: 38526543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in
    Liu Z; Yin K; Liu H; Wang N; Yao J; Zhou J; Tang Y; Yin Z
    Front Pharmacol; 2023; 14():1310339. PubMed ID: 38143499
    [No Abstract]   [Full Text] [Related]  

  • 27. Retrospective evaluation of LCP-tacrolimus (Envarsus XR) dosing in de novo kidney transplant.
    Alzahrani M; Belcher RM; Benken J; Valdepenas B; Di Cocco P; Kajavathanan M; Benken ST
    Clin Transplant; 2023 Nov; 37(11):e15082. PubMed ID: 37519278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.
    Gastaca M; Valdivieso A; Bustamante J; Fernández JR; Ruiz P; Ventoso A; Testillano M; Palomares I; Salvador P; Prieto M; Montejo M; Suárez MJ; de Urbina JO
    Liver Transpl; 2016 Oct; 22(10):1391-400. PubMed ID: 27434676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of the conversion to MeltDose
    Sánchez Fructuoso A; Ruiz JC; Franco A; Diekmann F; Redondo D; Calviño J; Serra N; Aladrén MJ; Cigarrán S; Manonelles A; Ramos A; Gómez G; González Posada JM; Andrés A; Beneyto I; Muñiz AL; Perelló M; Lauzurica R
    Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients.
    Torabi J; Konicki A; Rocca JP; Ajaimy M; Campbell A; Azzi Y; Pynadath C; Liriano-Ward L; Akalin E; Kinkhabwala M; Graham JA
    Am J Surg; 2020 Apr; 219(4):583-586. PubMed ID: 32122660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Effectiveness of Once-Daily, Prolonged-Release Tacrolimus in De Novo Kidney Transplant Recipients: 5-year, Multicenter Postmarketing Surveillance in Japan.
    Wakasugi N; Uchida H; Uno S
    Transplant Proc; 2018 Dec; 50(10):3296-3305. PubMed ID: 30577199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from Standard-Release Tacrolimus to MeltDose
    von Einsiedel J; Thölking G; Wilms C; Vorona E; Bokemeyer A; Schmidt HH; Kabar I; Hüsing-Kabar A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac.
    Thölking G; Tosun-Koç F; Jehn U; Koch R; Pavenstädt H; Suwelack B; Reuter S
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended-Release Once-Daily Tacrolimus Tablets.
    Philosophe B; Leca N; West-Thielke PM; Horwedel T; Culkin-Gemmell C; Kistler K; Stevens DR
    J Clin Pharmacol; 2018 Jul; 58(7):891-896. PubMed ID: 29462506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients.
    Charco R; Caralt M; Lladó L; Valdivieso A; Fabregat J; Matarranz A; Gonzalez-Pinto I; Pardo F; Fábrega E; Bilbao I
    Transplant Proc; 2011 Apr; 43(3):718-23. PubMed ID: 21486582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
    Langone A; Steinberg SM; Gedaly R; Chan LK; Shah T; Sethi KD; Nigro V; Morgan JC;
    Clin Transplant; 2015 Sep; 29(9):796-805. PubMed ID: 26113208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.
    Vondrak K; Parisi F; Dhawan A; Grenda R; Webb NJA; Marks SD; Debray D; Holt RCL; Lachaux A; Kelly D; Kazeem G; Undre N
    Clin Transplant; 2019 Oct; 33(10):e13698. PubMed ID: 31436896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study.
    Rubik J; Debray D; Kelly D; Iserin F; Webb NJA; Czubkowski P; Vondrak K; Sellier-Leclerc AL; Rivet C; Riva S; Tönshoff B; D'Antiga L; Marks SD; Reding R; Kazeem G; Undre N
    Transpl Int; 2019 Nov; 32(11):1182-1193. PubMed ID: 31325368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of prolonged-release versus immediate-release tacrolimus in
    Kim MS; Joh JW; Kim DS; Kim SH; Choi JS; Lee J; Lee JY; Kim JM; Kwon CHD; Choi GS; Yu YD; Yoon YI; Han JH; Lee YJ; Jiang H; Kim SI
    Korean J Transplant; 2019 Jun; 33(2):20-29. PubMed ID: 35769149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
    Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
    Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.